SEC Form 4 · accession 0001140361-18-004935
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Sleep Business
Period of report
Feb 1, 2018
Accepted (ET)
Feb 5, 2018 · 1:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF2 | Feb 1, 2018 | S | 600 | $100.11 | D | 62,002 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule10b5-1 Plan.
- F2This transaction was executed in multiple trades at prices ranging from $100.10 to $100.18. The price reported above reflects the weighted average sale price.